If a life-threatening heart disease is severe and acute, such as a case of a heart attack or cardiac arrest, it is even the survival of considerable stress to the patient. As a result, many patients experience symptoms, the diagnosis of post-traumatic stress disorder mean including intense fear, painful intrusive memories and hyperarousal, which is a state of internal stress due to the fight – or-flight response. According to the article PTSD between between 8 percent and 20 percent of patients with acute coronary syndromes and by 27 percent to 38 percent of cardiac arrest survivors.
Fajadet. ‘It has an innovative design and impressive performance, the benefit interventional cardiologists and their. ‘.. The NC Quantum Apex Catheter is a high-performance, post – dilatation balloon catheter developed specifically to address physicians ‘ needs in optimizing coronary stent. It represents the next generation of balloon catheter technology, and is designed to deliver enhanced performance through the use of a new Bi – Segment Inner Shaft provide for improved traceability and a redesigned tip for greater flexibility . It is available in a wide range of diameters of two balloons. With balloon lengths ranging from 6 to 30 mm The Monorai catheter platform will be available worldwide and both the Monorail and Over-the – Wire catheter platforms will be available in the U.S.
Jean Fajadet, Director of the Interventional Cardiology Unit, Clinique Pasteur, Toulouse, France was the first physician to with the new with the new balloon catheter.150 years research Lead The Way in the clotting process discovery of.
– a large effects affect to treat and prevent on heart disease and stroke was A include Monash-led research team a brand new mechanism that formation of blood clots formation of blood clots discovered.
Spite of intensive research over the last 40 years in discovering and development of more effective anti-coagulant drugs, was the effects of these treatments to mortality remained disappointingly low, to avoid to less than one in six patients, the anticoagulant treatment a fatal blood coagulation organization.